Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring Année : 2018

Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease

Niels Kruse
  • Fonction : Auteur
Amanda Heslegrave
  • Fonction : Auteur
Vandana Gupta
  • Fonction : Auteur
Martha Foiani
  • Fonction : Auteur
Anna Villar-Piqué
  • Fonction : Auteur
Matthias Schmitz
  • Fonction : Auteur
Brit Mollenhauer
Inga Zerr
  • Fonction : Auteur
Franc Llorens

Résumé

INTRODUCTION: Cerebrospinal fluid α-synuclein level is increased in sporadic Creutzfeldt-Jakob disease cases. However, the clinical value of this biomarker remains to be established. In this study, we have addressed the clinical validation parameters and the interlaboratory reproducibility by using an electrochemiluminescent assay. METHODS: Cerebrospinal fluid α-synuclein was quantified in a total of 188 sporadic Creutzfeldt-Jakob disease and non-Creutzfeldt-Jakob-disease cases to determine sensitivity and specificity values and lot-to-lot variability. Two round robin tests with 70 additional cases were performed in six independent laboratories. RESULTS: A sensitivity of 93% and a specificity of 96% were achieved in discriminating sporadic Creutzfeldt-Jakob disease. No differences were detected between lots. The mean interlaboratory coefficient of variation was 23%, and the intralaboratory coefficient of variations ranged 2.70%-11.39%. Overall, 97% of samples were correctly diagnosed. DISCUSSION: The herein validated α-synuclein assay is robust, accurate, and reproducible in identifying Creutzfeldt-Jakob disease cases. Thus, it is ready for implementation in the clinical practice to support the diagnosis of Creutzfeldt-Jakob disease.
Fichier principal
Vignette du fichier
main (1).pdf (766.65 Ko) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02313965 , version 1 (27-02-2020)

Identifiants

Citer

Niels Kruse, Amanda Heslegrave, Vandana Gupta, Martha Foiani, Anna Villar-Piqué, et al.. Interlaboratory validation of cerebrospinal fluid α-synuclein quantification in the diagnosis of sporadic Creutzfeldt-Jakob disease. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2018, 10, pp.461--470. ⟨10.1016/j.dadm.2018.06.005⟩. ⟨hal-02313965⟩
154 Consultations
139 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More